Janssen reports positive results in Phase III combination trial to treat HIV

Janssen Sciences Ireland (Janssen) has reported positive results in the first of the two Phase III studies that evaluate the safety and efficacy of switching virologically suppressed patients from a three or four drug anti-retroviral regimen to the t …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news